JPS5632450A - Aniline derivative* its manufacture and medicine containing it - Google Patents

Aniline derivative* its manufacture and medicine containing it

Info

Publication number
JPS5632450A
JPS5632450A JP8082580A JP8082580A JPS5632450A JP S5632450 A JPS5632450 A JP S5632450A JP 8082580 A JP8082580 A JP 8082580A JP 8082580 A JP8082580 A JP 8082580A JP S5632450 A JPS5632450 A JP S5632450A
Authority
JP
Japan
Prior art keywords
group
manufacture
aniline derivative
medicine containing
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8082580A
Other languages
English (en)
Inventor
Desukamu Maruseru
Goorudenberugu Shiyaruru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS5632450A publication Critical patent/JPS5632450A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
JP8082580A 1979-06-14 1980-06-13 Aniline derivative* its manufacture and medicine containing it Pending JPS5632450A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7915232A FR2459235A1 (fr) 1979-06-14 1979-06-14 Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique

Publications (1)

Publication Number Publication Date
JPS5632450A true JPS5632450A (en) 1981-04-01

Family

ID=9226608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8082580A Pending JPS5632450A (en) 1979-06-14 1980-06-13 Aniline derivative* its manufacture and medicine containing it

Country Status (6)

Country Link
US (1) US4330542A (ja)
EP (1) EP0022118B1 (ja)
JP (1) JPS5632450A (ja)
AT (1) ATE3638T1 (ja)
DE (1) DE3063594D1 (ja)
FR (1) FR2459235A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
US20040122000A1 (en) * 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
DE3276313D1 (en) * 1981-09-24 1987-06-19 Beecham Wuelfing Gmbh & Co Kg Sulphonamides
JP2556722B2 (ja) * 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
FR2655652B1 (fr) * 1989-12-13 1994-06-10 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et les medicaments les contenant.
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
US5783701A (en) 1992-09-08 1998-07-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
GB9310095D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
AU699483B2 (en) * 1994-03-07 1998-12-03 Vertex Pharmaceuticals Incorporated Sulphonamide derivatives as aspartyl protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6004957A (en) * 1995-06-07 1999-12-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
US5883252A (en) * 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US6960579B1 (en) * 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
WO1999065870A2 (en) * 1998-06-19 1999-12-23 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease
US20020155088A1 (en) * 2001-04-23 2002-10-24 Chiang Long Y. Tumor treatment by using oligoaniline
JP5025795B2 (ja) * 2008-06-05 2012-09-12 旭化成ファーマ株式会社 スルホンアミド化合物及びその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2575122A (en) * 1950-10-11 1951-11-13 Parke Davis & Co Piperazine compounds
JPS49101383A (ja) * 1973-02-05 1974-09-25
SE403611B (sv) * 1975-09-05 1978-08-28 Berol Kemi Ab Forfarande for framstellning av en reaktionsprodukt mellan en epoxid och en organisk forening innehallande reaktivt vete i nervaro av viss angiven katalysator
DE2623314C2 (de) * 1976-05-25 1984-08-02 Hoechst Ag, 6230 Frankfurt 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ES469020A1 (es) * 1977-05-10 1979-09-01 Kali Chemie Pharma Gmbh Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos

Also Published As

Publication number Publication date
ATE3638T1 (de) 1983-06-15
DE3063594D1 (en) 1983-07-07
EP0022118B1 (fr) 1983-06-01
US4330542A (en) 1982-05-18
FR2459235B1 (ja) 1982-09-17
EP0022118A1 (fr) 1981-01-07
FR2459235A1 (fr) 1981-01-09

Similar Documents

Publication Publication Date Title
JPS5632450A (en) Aniline derivative* its manufacture and medicine containing it
SE7907121L (sv) Ftalimidinderivat
SE8406585D0 (sv) Benzoic acid derivatives
HUT42476A (en) Herbicidal compositions comprising 4,5-disubstituted 1,3-thiazol-2-yl-oxy-acetamide derivatives as active substance and process for preparing the active substances
DE3668171D1 (de) 1-aryl-5-alkoximinoalkylamino-pyrazole.
ES480391A1 (es) Un procedimiento para la preparacion de derivados de difeni-lamina.
ES441183A1 (es) Un procedimiento para preparar derivados de fosforotiolato.
ES8100796A1 (es) Un procedimiento para la preparacion de derivados de n-(fenilcicloalquil)acelamida
AU597923B2 (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
ES440195A1 (es) Procedimiento para la preparacion de derivados de favona.
DE3061396D1 (en) Oxazoline and thiazoline derivatives, processes for their preparation and pharmaceutical compositions containing them
DK553482A (da) Fremgangsmaade til fremstilling af n,n-disubstituerede alkenamider og phenylalkenamider
GB2001531A (en) Organic compounds
ES445960A1 (es) Procedimiento de preparacion de derivados fosforados.
MY103239A (en) A benzoylurea derivative and its production and use
SE8302547L (sv) Heterocykliska amider av fenoxifenoxialkansyror
CH653840GA3 (en) Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds
ATE15200T1 (de) Organozinnverbindungen.
ES475875A1 (es) Procedimiento para la preparacion de derivados de ureido-3- (tio)cromona.
DE3173404D1 (en) Biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
IL76155A0 (en) Benzoylurea derivatives,their preparation and pesticidal compositions containing them
HUT39076A (en) Insecticidal and acaricidal compositions comprising new benzoyl-urea-derivatives as active substance and process for preparing the active substance
AU557502B2 (en) Dithiino(1,4)(2,3-c)pyrrole derivatives